A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy
Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
This study was designed to assess the safety and efficacy of AQUAVAN® Injection in providing
adequate sedation in patients undergoing colonoscopy. Prior to the procedure, patients
received fentanyl citrate for pain management followed five minutes later by AQUAVAN®
Injection for sedation. Throughout the procedure, study personnel assessed the patient's
vital signs and depth of sedation. After the procedure, the patient, physician, and an
evaluator were asked to complete satisfaction surveys.
Phase:
Phase 2
Details
Lead Sponsor:
Eisai Inc.
Collaborators:
Bio Analytical Research Corporation HHI Clinical Research (Biostatistics) MDS Pharma Services Omnicare Clinical Research The Coghlan Group (Plasma Sample Supplies)